These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32785223)

  • 21. Antibiotic resistance: consequences of inaction.
    Levy SB
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S124-9. PubMed ID: 11524708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Optimal graduate studies in the field of community medicine].
    Golovan' DI; Bobrul' ZA
    Gig Sanit; 1990 Nov; (11):63-4. PubMed ID: 2093595
    [No Abstract]   [Full Text] [Related]  

  • 23. Advancing the science of medicines regulation: the role of the 21st-century medicines regulator.
    Lumpkin MM; Eichler HG; Breckenridge A; Hamburg MA; Lönngren T; Woods K
    Clin Pharmacol Ther; 2012 Oct; 92(4):486-93. PubMed ID: 22948890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iodized household salt utilization and associated factors among households in East Africa: a multilevel modelling analysis using recent national health surveys.
    Terefe B; Jembere MM; Assimamaw NT
    BMC Public Health; 2023 Dec; 23(1):2387. PubMed ID: 38041025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Encouragement in community medicine].
    Bjørndal A; Grimsmo A
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):12-3. PubMed ID: 8296272
    [No Abstract]   [Full Text] [Related]  

  • 26. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
    Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
    Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases.
    Bollyky TJ; Cockburn IM; Berndt E
    Clin Trials; 2010 Dec; 7(6):719-34. PubMed ID: 21109581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collaborative health and enforcement operations on the quality of antimalarials and antibiotics in southeast Asia.
    Yong YL; Plançon A; Lau YH; Hostetler DM; Fernández FM; Green MD; Sounvoravong S; Nara S; Boravann M; Dumrong T; Bangsawan N; Low MY; Lim CC; Ai RLC; Newton PN
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):105-112. PubMed ID: 25897069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vienna Declaration: a call for evidence-based drug policies.
    Wood E; Werb D; Kazatchkine M; Kerr T; Hankins C; Gorna R; Nutt D; Des Jarlais D; Barré-Sinoussi F; Montaner J
    Lancet; 2010 Jul; 376(9738):310-2. PubMed ID: 20650517
    [No Abstract]   [Full Text] [Related]  

  • 30. The social, professional, and legal framework for the problem of pain management in emergency medicine.
    Johnson SH
    J Law Med Ethics; 2005; 33(4):741-60. PubMed ID: 16686244
    [No Abstract]   [Full Text] [Related]  

  • 31. [Harmonization in laboratory medicine: a current approach to improving the quality of clinical and laboratory studies].
    Khorovskaia LA; Kallner A; Emanuél' VL
    Klin Lab Diagn; 2008 Mar; (3):25-32. PubMed ID: 18450081
    [No Abstract]   [Full Text] [Related]  

  • 32. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
    BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory challenges for new formulations of controlled substances in today's environment.
    McCormick CG
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S63-7. PubMed ID: 16567060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community medicine in the United Kingdom. Medical education and an emerging specialty within the reorganized National Health Service.
    Jordan WS
    Springer Ser Health Care Soc; 1978; 2():iii-310. PubMed ID: 10259686
    [No Abstract]   [Full Text] [Related]  

  • 36. "Should we support calls to decriminalise drug use"?
    Riddell S
    Nurs Times; 2011 Jan 25-31; 107(3):13. PubMed ID: 21329078
    [No Abstract]   [Full Text] [Related]  

  • 37. COPE (client-oriented, provider-efficient), a model for building community partnerships that improve care in East Africa.
    Dohlie MB; Mielke E; Bwire T; Adriance D; Mumba F
    J Healthc Qual; 2000; 22(5):34-9. PubMed ID: 11184028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quality control in the practice of medicine].
    Viniegra-Velázquez L; Corvera-Bernardelli J; Arroyo P
    Gac Med Mex; 1990; 126(4):283-95. PubMed ID: 2093565
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulatory watch: Innovative drug availability in China.
    Shao L; Xu L; Li Q; Chakravarthy R; Yang Z; Kaitin KI
    Nat Rev Drug Discov; 2016 Nov; 15(11):739-740. PubMed ID: 27765941
    [No Abstract]   [Full Text] [Related]  

  • 40. Biospecimens and biorepositories for the community pathologist.
    Dash RC; Robb JA; Booker DL; Foo WC; Witte DL; Bry L
    Arch Pathol Lab Med; 2012 Jun; 136(6):668-78. PubMed ID: 22646276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.